---
figid: PMC7544979__gr1
figtitle: 'Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update'
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7544979
filename: gr1.jpg
figlink: /pmc/articles/PMC7544979/figure/fig1/
number: F1
caption: VEGF/VEGFR2 Signaling Pathway in Endothelial Cell Relevant to AngiogenesisThe
  VEGF-VEGFR2 system engages activation of PI3K, p38MAPK, FAK, and PLCγ. PI3K, in
  turn, activates AKT and Rac, resulting in cell survival and increased vascular permeability,
  respectively. PLCγ, in turn, activates PKC with the downstream MAPK cascade facilitating
  cell proliferation and cell motility. Both p38MAPK and FAK mediate cell mobility.
  The combined effects of these pathways on the vascular endothelium result in angiogenesis.
  VEGF, vascular endothelial growth factor; VEGFR2, VEGF receptor 2; PLCγ, phospholipase
  C gamma; PI3K, phosphatidylinositol 3-kinase; PKC, protein kinase C; MAPK, mitogen-activated
  protein kinase; FAK, focal adhesion kinase; eNOS, endothelial nitric oxide synthase.
papertitle: 'Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update.'
reftext: Fan-Li Lin, et al. Mol Ther. 2020 Oct 7;28(10):2120-2138.
year: '2020'
doi: 10.1016/j.ymthe.2020.06.029
journal_title: Molecular Therapy
journal_nlm_ta: Mol Ther
publisher_name: American Society of Gene & Cell Therapy
keywords: neovascularization | eye | gene therapy | VEGF | age-related macular degeneration
  | diabetic retinopathy
automl_pathway: 0.9453054
figid_alias: PMC7544979__F1
figtype: Figure
redirect_from: /figures/PMC7544979__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7544979__gr1.html
  '@type': Dataset
  description: VEGF/VEGFR2 Signaling Pathway in Endothelial Cell Relevant to AngiogenesisThe
    VEGF-VEGFR2 system engages activation of PI3K, p38MAPK, FAK, and PLCγ. PI3K, in
    turn, activates AKT and Rac, resulting in cell survival and increased vascular
    permeability, respectively. PLCγ, in turn, activates PKC with the downstream MAPK
    cascade facilitating cell proliferation and cell motility. Both p38MAPK and FAK
    mediate cell mobility. The combined effects of these pathways on the vascular
    endothelium result in angiogenesis. VEGF, vascular endothelial growth factor;
    VEGFR2, VEGF receptor 2; PLCγ, phospholipase C gamma; PI3K, phosphatidylinositol
    3-kinase; PKC, protein kinase C; MAPK, mitogen-activated protein kinase; FAK,
    focal adhesion kinase; eNOS, endothelial nitric oxide synthase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLCG1
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PTK2
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - KDR
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NOS3
  - ENO4
  - AKT2
  - AKT3
  - sl
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Fak
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - MKP-4
  - rl
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
---
